Defining the need for cardiovascular event definitions

Authors:

Abstract
There has been a transformation in clinical care and outcomes for patients with cardiovascular disease in recent times. This has largely been enabled by the robust evaluation of the safety and efficacy of new pharmaceutical agents and health technologies in randomized clinical trials (RCT). Integral to this progress is the judicious and a priori selection and definition of key cardiovascular outcome measures against which an intervention is assessed and evaluated.1

This publication has 14 references indexed in Scilit: